Skip to main content

Peer Review reports

From: When tyrosine kinase inhibitor sunitinib can be discontinued in metastatic renal cell carcinoma to pancreas: a case report

Original Submission
4 Sep 2017 Submitted Original manuscript
19 Nov 2017 Reviewed Reviewer Report - SM Ali
23 Nov 2017 Reviewed Reviewer Report - Rahul Arora
7 Dec 2017 Author responded Author comments - yassir sbitti
Resubmission - Version 2
7 Dec 2017 Submitted Manuscript version 2
29 Jan 2018 Author responded Author comments - yassir sbitti
Resubmission - Version 3
29 Jan 2018 Submitted Manuscript version 3
Publishing
30 Jan 2018 Editorially accepted
20 Mar 2018 Article published 10.1186/s13256-018-1597-z

You can find further information about peer review here.

Back to article page